皮肤化妆品市场－全球产业规模、份额、趋势、机会和预测：产品类型、治疗类型、最终用户、分销管道、地区和竞争格局，2021-2031年

全球皮肤化妆品市场预计将从 2025 年的 566.9 亿美元成长到 2031 年的 912.2 亿美元，复合年增长率达到 8.25%。

皮肤护理产品位于化妆品和药品的交叉领域，是专门针对特定皮肤问题（例如衰老、色素沉着和痤疮）而设计的配方，旨在促进皮肤健康。市场成长的主要驱动因素包括全球皮肤疾病发病率的上升、人口老化导致人们倾向于选择非侵入性美容方式，以及消费者对经临床科学验证的成分的需求不断增长。此外，数位平台的普及化进一步放大了这些因素，提高了专业级产品的可近性，并使消费者能够在传统医疗机构之外获得针对性的治疗。

然而，由于各地区法规环境复杂且分散，该行业面临许多挑战，导致产品核准延迟，并增加了製造商的合规成本。仿冒品的存在往往会加剧这种监管负担，并损害品牌声誉。为了凸显该行业的重要性，《欧洲化妆品》杂誌报告称，预计到2024年，欧洲个人护理和化妆品市场规模将达到1039亿欧元，其中护肤品（包括皮肤护理产品）将占据最大份额，达28.9%。这些数据表明，皮肤健康解决方案对整个个人护理市场做出了显着的经济贡献。

市场驱动因素

皮肤疾病和皮肤问题的日益增加是推动市场扩张的主要动力，从根本上改变了消费者的护肤重点。随着都市化、环境压力和生活方式改变等因素导致皮肤疾病发病率上升，消费者正积极寻求能够带来实际医疗改善的治疗方案，而不仅仅是追求美容效果。例如，《皮肤病学时报》2025年6月刊发表了报导，指出美国2021年新增痤疮病例超过440万例，比2010年增长了14.3%。诊断病例的激增正在推动行业结构性变革，并增加了对能够有效治疗特定皮肤疾病的专业皮肤护理配方的需求。

同时，意识提升，也推动了市场的发展。现今的消费者越来越了解胜肽、神经酰胺和类视色素等成分，并且倾向于选择经过科学验证的、功效卓着的产品，而非普通的美容产品。这种对功效的偏好也体现在企业的财务数据中。例如，高德美公司在2025年3月发布的报告显示，其皮肤科护肤部门的净销售额将达到13.31亿美元，年增10.7%，这主要得益于其高端科学产品系列。这一趋势展现了该产业的强劲经济实力。欧莱雅金融发布的2025年报告预测，其2024年皮肤科美容部门的销售额将超过70亿欧元，进一步印证了全球对高效皮肤健康解决方案的持续需求。

市场挑战

全球范围内复杂且分散的法规结构对皮肤化妆品市场的成长构成了重大障碍。製造商必须应对大量相互衝突的合规标准，这往往迫使他们花费巨资重新设计产品并进行重复测试，以满足当地法规的要求。这种缺乏协调性的做法增加了营运成本，延长了新产品的上市时间，从而降低了企业应对新兴消费趋势的灵活性。因此，原本可以用于创新的资源被转移到了政府合规方面，对营运效率造成了沉重的负担。

这种充满挑战的法规环境尤其影响品牌扩充性，因为产品出口障碍限制了潜在收入。儘管该行业高度依赖国际贸易，但监管方面的不一致仍然威胁着这项贸易。根据欧洲化妆品协会（Cosmetics Europe）预测，到2024年，欧洲化妆品产业的全球出口额预计将超过290亿欧元。虽然这个数字凸显了跨境贸易的重要性，但不同监管体系造成的摩擦阻碍了出口能力的充分利用，最终减缓了整体经济成长。

市场趋势

生物技术在永续活性成分领域的应用日益广泛，正在改变全球皮肤化妆品市场。製造商正从传统的萃取方法转向纯度更高、环境影响更小的替代种植方法。这种转变促进了高效配方（包括生物发酵活性成分）的研发，满足了消费者对永续性和经皮肤科验证的功效的需求，同时又不消耗自然资源。支撑这项转变的经济动力在供应链中也显而易见。根据奇华顿公司于2025年1月发布的“2024财年全年业绩报告”，其活性美容部门实现了11.1%的同比增长，表明市场对这些高性能生物基成分的需求不断增长。

同时，人工智慧驱动的皮肤诊断和个人化技术的快速融合，正从根本上改变消费者发现和选择护肤方案的方式，将专业皮肤科与居家护理相结合。借助以数据为中心的演算法，品牌可以直接向用户提供先进的皮肤分析和客製化的产品提案，而这需要对数位生态系统进行大量投资。为了体现这一策略重点，拜尔斯道夫在2025年2月发布的2024年度报告中揭露，该公司已将其在数位媒体上的广告支出提高至总广告支出的70%。这凸显了精准的数位平台在提供个人化护肤解决方案方面的重要性。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球肌肤化妆品市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品种类（护肤（乳霜、乳液、洗面乳等）、护髮品（洗髮精、护髮素、精油等））
  • 治疗类型（皮肤（抗衰老、痤疮治疗、其他）、头髮（去屑、防脱髮、头髮再生、其他））
  • 依最终使用者（诊所、水疗中心和美容院、医院、家庭）划分
  • 按分销管道（药局/药局、线上、非零售通路）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美皮肤化妆品市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲皮肤化妆品市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章 亚太地区皮肤化妆品市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲皮肤化妆品市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲皮肤化妆品市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球皮肤化妆品市场展望

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• The Procter & Gamble Company
• L'Oreal SA
• Unilever PLC
• Johnson & Johnson Services, Inc.
• The Avon Company
• Bausch Health Companies Inc.
• Galderma SA
• Kanebo Cosmetics Inc.
• Beiersdorf AG
• AMOREPACIFIC US, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Dermocosmetics Market is projected to expand from USD 56.69 Billion in 2025 to USD 91.22 Billion by 2031, achieving a CAGR of 8.25%. Situated at the convergence of cosmetics and pharmaceuticals, dermocosmetics are specialized formulations engineered to enhance skin health by treating specific dermatological issues such as aging, hyperpigmentation, and acne. The market's growth is largely fueled by the increasing global incidence of skin conditions, an aging demographic favoring non-invasive aesthetic options, and a rising consumer demand for ingredients backed by clinical science. These drivers are further amplified by the proliferation of digital platforms, which have improved the accessibility of professional-grade products, allowing consumers to secure targeted treatments outside of conventional medical environments.

However, the industry faces substantial hurdles due to a complicated and disjointed regulatory environment across various regions, which can retard product approvals and elevate compliance costs for manufacturers. This regulatory strain is frequently exacerbated by the presence of counterfeit products that threaten brand reputation. Highlighting the economic significance of the sector, Cosmetics Europe reported that the European personal care and cosmetics market was valued at 103.9 billion euros in 2024, with the skin care segment-which includes dermocosmetics-commanding the largest share at 28.9%. This data emphasizes the vital economic contribution of skin health solutions within the broader personal care landscape.

Market Driver

The escalating prevalence of dermatological disorders and skin conditions serves as a primary engine for market expansion, fundamentally shifting consumer skincare priorities. As factors such as urbanization, environmental stressors, and lifestyle changes increase the incidence of skin ailments, consumers are actively searching for therapeutic solutions that provide tangible medical improvements rather than just aesthetic enhancements. Highlighting this growing issue, a June 2025 article in Dermatology Times titled 'The Growing Burden of Acne in America' noted that the US recorded over 4.4 million new cases of acne in 2021, marking a 14.3% rise since 2010. This surge in diagnoses is driving a structural transformation in the industry, necessitating specialized dermocosmetic formulations capable of effectively managing specific pathologies.

Simultaneously, the market is driven by heightened consumer awareness regarding active ingredients and clinical efficacy. Modern shoppers are increasingly knowledgeable about components like peptides, ceramides, and retinoids, favoring science-backed products with verified results over generic beauty items. This preference for validated performance is reflected in corporate financials; for instance, Galderma's 'Full Year 2024 Results' from March 2025 reported that its Dermatological Skincare net sales hit 1.331 billion USD, achieving 10.7% growth due to its premium scientific portfolio. This trend demonstrates the sector's economic strength, further evidenced by L'Oreal Finance, which reported in 2025 that its Dermatological Beauty Division generated sales exceeding 7 billion euros in 2024, confirming the sustained global demand for effective skin health solutions.

Market Challenge

The complicated and fragmented regulatory framework across various global regions acts as a major impediment to the growth of the dermocosmetics market. Manufacturers must navigate a conflicting array of compliance standards, a reality that often forces expensive product reformulations and redundant testing to satisfy local requirements. This lack of harmonization increases operational costs and prolongs the time-to-market for new products, thereby diminishing the agility of companies to respond to emerging consumer trends. Consequently, resources that could otherwise be invested in innovation are diverted toward administrative compliance, creating a significant burden on operational efficiency.

This difficult regulatory environment particularly impacts the international scalability of brands, as barriers to seamless product exportation restrict potential revenue. While the sector relies heavily on global trade, regulatory discrepancies continually threaten this exchange. According to Cosmetics Europe, the European cosmetics industry recorded global exports surpassing 29 billion euros in 2024. Although this figure underscores the critical nature of cross-border commerce, the friction generated by divergent regulatory systems prevents the market from fully exploiting this export capacity, ultimately slowing broader economic expansion.

Market Trends

The growing application of biotechnology for sustainable active ingredients is transforming the global dermocosmetics market, as manufacturers move from traditional extraction methods to lab-grown alternatives that ensure higher purity and reduced environmental impact. This shift facilitates the development of potent formulations, such as bio-fermented actives, which address the dual consumer desire for sustainability and proven dermatological efficacy without depleting natural resources. The economic momentum behind this transition is evident in the supply chain; according to Givaudan's '2024 Full year results' published in January 2025, the company's Active Beauty division achieved a like-for-like growth of 11.1%, signaling surging industrial demand for these high-performance, bio-based components.

Concurrently, the rapid integration of AI-driven skin diagnostics and personalization is fundamentally altering how consumers discover and select skincare routines by connecting professional dermatology with home care. By utilizing data-centric algorithms, brands can provide sophisticated skin analysis and customized product recommendations directly to users, a capability that necessitates significant investment in digital ecosystems. Reflecting this strategic focus, Beiersdorf's 'Annual Report 2024', released in February 2025, revealed that the company increased its digital working media spend to 70% of its total working media expenditure, highlighting the essential role of targeted digital platforms in delivering personalized skincare solutions.

Key Market Players

• The Procter & Gamble Company
• L'Oreal S.A
• Unilever PLC
• Johnson & Johnson Services, Inc.
• The Avon Company
• Bausch Health Companies Inc.
• Galderma SA
• Kanebo Cosmetics Inc.
• Beiersdorf AG
• AMOREPACIFIC US, Inc.

Report Scope

In this report, the Global Dermocosmetics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dermocosmetics Market, By Product Type

• Skincare (Cream, Lotion, Cleanser, Others)
• Haircare (Shampoo, Conditioner, Oil, Others)

Dermocosmetics Market, By Treatment Type

• Skin (Anti-Aging, Acne-Treatment, Others)
• Hair (Anti-Dandruff, Anti-Hair Fall, Hair Repair, Others)

Dermocosmetics Market, By End-User

• Clinics
• Spas & Salons
• Hospitals
• At Home

Dermocosmetics Market, By Distribution Channel

• Pharmacy & Drug Stores
• Online
• Non-Retail

Dermocosmetics Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dermocosmetics Market.

Available Customizations:

Global Dermocosmetics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dermocosmetics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Skincare (Cream, Lotion, Cleanser, Others), Haircare (Shampoo, Conditioner, Oil, Others))
  • 5.2.2. By Treatment Type (Skin (Anti-Aging, Acne-Treatment, Others), Hair (Anti-Dandruff, Anti-Hair Fall, Hair Repair, Others))
  • 5.2.3. By End-User (Clinics, Spas & Salons, Hospitals, At Home)
  • 5.2.4. By Distribution Channel (Pharmacy & Drug Stores, Online, Non-Retail)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Dermocosmetics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Treatment Type
  • 6.2.3. By End-User
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Dermocosmetics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Treatment Type
      • 6.3.1.2.3. By End-User
      • 6.3.1.2.4. By Distribution Channel
  • 6.3.2. Canada Dermocosmetics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Treatment Type
      • 6.3.2.2.3. By End-User
      • 6.3.2.2.4. By Distribution Channel
  • 6.3.3. Mexico Dermocosmetics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Treatment Type
      • 6.3.3.2.3. By End-User
      • 6.3.3.2.4. By Distribution Channel

7. Europe Dermocosmetics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Treatment Type
  • 7.2.3. By End-User
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Dermocosmetics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Treatment Type
      • 7.3.1.2.3. By End-User
      • 7.3.1.2.4. By Distribution Channel
  • 7.3.2. France Dermocosmetics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Treatment Type
      • 7.3.2.2.3. By End-User
      • 7.3.2.2.4. By Distribution Channel
  • 7.3.3. United Kingdom Dermocosmetics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Treatment Type
      • 7.3.3.2.3. By End-User
      • 7.3.3.2.4. By Distribution Channel
  • 7.3.4. Italy Dermocosmetics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Treatment Type
      • 7.3.4.2.3. By End-User
      • 7.3.4.2.4. By Distribution Channel
  • 7.3.5. Spain Dermocosmetics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Treatment Type
      • 7.3.5.2.3. By End-User
      • 7.3.5.2.4. By Distribution Channel

8. Asia Pacific Dermocosmetics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Treatment Type
  • 8.2.3. By End-User
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Dermocosmetics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Treatment Type
      • 8.3.1.2.3. By End-User
      • 8.3.1.2.4. By Distribution Channel
  • 8.3.2. India Dermocosmetics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Treatment Type
      • 8.3.2.2.3. By End-User
      • 8.3.2.2.4. By Distribution Channel
  • 8.3.3. Japan Dermocosmetics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Treatment Type
      • 8.3.3.2.3. By End-User
      • 8.3.3.2.4. By Distribution Channel
  • 8.3.4. South Korea Dermocosmetics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Treatment Type
      • 8.3.4.2.3. By End-User
      • 8.3.4.2.4. By Distribution Channel
  • 8.3.5. Australia Dermocosmetics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Treatment Type
      • 8.3.5.2.3. By End-User
      • 8.3.5.2.4. By Distribution Channel

9. Middle East & Africa Dermocosmetics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Treatment Type
  • 9.2.3. By End-User
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Dermocosmetics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Treatment Type
      • 9.3.1.2.3. By End-User
      • 9.3.1.2.4. By Distribution Channel
  • 9.3.2. UAE Dermocosmetics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Treatment Type
      • 9.3.2.2.3. By End-User
      • 9.3.2.2.4. By Distribution Channel
  • 9.3.3. South Africa Dermocosmetics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Treatment Type
      • 9.3.3.2.3. By End-User
      • 9.3.3.2.4. By Distribution Channel

10. South America Dermocosmetics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Treatment Type
  • 10.2.3. By End-User
  • 10.2.4. By Distribution Channel
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Dermocosmetics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Treatment Type
      • 10.3.1.2.3. By End-User
      • 10.3.1.2.4. By Distribution Channel
  • 10.3.2. Colombia Dermocosmetics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Treatment Type
      • 10.3.2.2.3. By End-User
      • 10.3.2.2.4. By Distribution Channel
  • 10.3.3. Argentina Dermocosmetics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Treatment Type
      • 10.3.3.2.3. By End-User
      • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Dermocosmetics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. The Procter & Gamble Company
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. L'Oreal S.A
• 15.3. Unilever PLC
• 15.4. Johnson & Johnson Services, Inc.
• 15.5. The Avon Company
• 15.6. Bausch Health Companies Inc.
• 15.7. Galderma SA
• 15.8. Kanebo Cosmetics Inc.
• 15.9. Beiersdorf AG
• 15.10. AMOREPACIFIC US, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer